Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-25 @ 5:25 PM
NCT ID:
NCT03483103
Group ID:
EG000
Title:
Lisocabtagene Maraleucel (JCAR017)
Description:
Participants underwent leukapheresis and may receive salvage low- dose chemotherapy or one cycle of non-curative standard of care antitumor therapy if required. Eligible participants then received lymphodepleting chemotherapy with fludarabine and cyclophosphamide (flu/cy) followed by a single dose of JCAR017 (100×10\^6 CAR+ T cells) administered intravenously (IV) 2 to 7 days after completion of lymphodepleting chemotherapy.
Deaths Number Affected:
30
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
61
Other Number Affected:
59
Other Number At Risk:
61
Study:
NCT03483103
Results Section:
NCT03483103
Adverse Events Module:
NCT03483103